A new study found that ChatGPT might actually be quite successful in providing high-quality answers to patient questions during an era in which doctors and nurses are too busy to do so. The research evaluated two sets of answers to patient inquiries — one written by physicians, the other by ChatGPT. A panel of healthcare professionals determined that ChatGPT's answers were significantly more detailed and empathetic.
Jeff Sherman, chief technology officer of Zephyr AI, a company that aims to transform precision medicine from diagnostics to treatment. How exactly does it plan to do that? Listen below to know more.
At MedCity INVEST we highlight the trends in investment and innovation across biopharma, diagnostics, medical devices and health tech (payer/provider and consumer/employer). This is your opportunity to connect and network in 5-star comfort. Last week to save $200.
Sanofi is acquiring rights to a Maze Therapeutics drug candidate for Pompe disease that could give the pharmaceutical giant another option to offer patients who have the rare metabolic disorder. In February, the drug posted positive data from a Phase 1 study.
Medicare could have saved $128 million if the Centers for Medicare and Medicaid Services had the correct controls in place to avoid duplicate payments with the Veterans Health Administration, an audit by the Office of Inspector General found.
This season, we will be focusing on artificial intelligence in healthcare. Our very first interview is with Jeff Sherman, chief technology officer of Zephyr AI, a company that aims to transform precision medicine from diagnostics to treatment. How exactly does it plan to do that? Listen to find out.
No comments:
Post a Comment